Kronox Lab Sciences Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2025, recommended Final Dividend of Rs. 5 per equity share.
KRONOX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts less than Nifty Microcap 250 and 2.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kronox Lab Sciences reported FY25 revenue from operations of Rs. 10,019.39 lakhs, up about 11.5% from Rs. 8,986.24 lakhs in FY24. Profit after tax grew to Rs. 2,546.71 lakhs (FY24: Rs. 2,135.13 lakhs), with EPS rising to Rs. 6.91 from Rs. 5.81. The Board has recommended a final dividend of Rs. 5 per share on equity capital of Rs. 3,710.40 lakhs (face value Rs. 10). The company posted strong operating cash flow of Rs. 3,069.66 lakhs and total equity rose to Rs. 9,010.49 lakhs. The statutory auditor (Mahesh Udhwani & Associates) issued an unmodified opinion on the results. The company recently listed on NSE/BSE in June 2024 and operates in a single segment: manufacturing of high purity specialty fine chemicals.
The double-digit revenue and profit growth, healthy cash generation, and maiden dividend declaration are positive signals for shareholders. A clean audit report with no qualifications further supports confidence, though revenue growth below 20% and dividend payout being the first post-listing suggests measured capital return rather than aggressive yield.